Skip to main content
. 2024 Mar 5;7(3):e241139. doi: 10.1001/jamanetworkopen.2024.1139

Table 1. Baseline Characteristics of Study Participants.

Characteristic Total RA status Serologic status of RA
No Yes P value SNRA SPRA P value
Participants, No. 230 922 192 435 38 487 NA 11 645 26 842 NA
Age, mean (SD), y 54.6 (12.1) 54.6 (12.1) 54.6 (12.1) NA 52.3 (12.8) 55.6 (11.6) NA
20-39 23 550 (10.2) 19 625 (10.2) 3925 (10.2) >.99 1905 (16.4) 2020 (7.5) <.001
40-59 127 242 (55.1) 106 035 (55.1) 21 207 (55.1) 6336 (54.4) 14 871 (55.4)
≥60 80 130 (34.7) 66 775 (34.7) 13 355 (34.7) 3404 (29.2) 9951 (37.1)
Sex
Male 66 996 (29.0) 55 830 (29.0) 11 166 (29.0) >.99 3928 (33.7) 7238 (27.0) <.001
Female 163 926 (71.0) 136 605 (71.0) 27 321 (71.0) 7717 (66.3) 19 604 (73.0)
Income
Low ≥25% Medicaid group 51 583 (22.3) 43 205 (22.5) 8378 (21.8) .003 2306 (19.8) 6072 (22.6) <.001
Smoking status
Never or former smoking 201 349 (87.2) 167 750 (87.2) 33 599 (87.2) .50 NA NA .97
Current smoking 29 573 (12.8) 24, 685 (12.8) 4888 (12.7) 1, 480 (12.7) 3408 (12.7)
Alcohol consumption
None 152 973 (66.2) 125 642 (65.3) 27 331 (71.0) <.001 NA NA <.001
>0 g/d 77 949 (33.8) 66 793 (34.7) 11 156 (29.0) 3835 (32.9) 7321 (27.3)
Physical activity
None 185 542 (80.3) 153 906 (80.0) 31 636 (82.2) <.001 NA NA .008
Regular 45 380 (19.7) 38 529 (20.0) 6851 (17.8) 2165 (18.6) 4686 (17.5)
BMI
<25 158 212 (68.5) 130 665 (67.9) 27 547 (71.6) <.001 NA NA <.001
≥25 72 710 (31.5) 61 770 (32.1) 10 940 (28.4) 3582 (30.8) 7358 (27.4)
Diabetes 25 438 (11.02) 21 356 (11.1) 4082 (10.6) .005 1233 (10.6) 2849 (10.6) .94
Hypertension 75 246 (32.6) 61 785 (32.1) 13 461 (35.0) <.001 4206 (36.1) 9255 (34.5) .002
Dyslipidemia 63 066 (27.3) 52 660 (27.4) 10 406 (27.0) .19 3324 (28.5) 7082 (26.4) <.001
Chronic kidney disease 12 971 (5.6) 10 270 (5.3) 2701 (7.0) <.001 895 (7.7) 1806 (6.7) .001

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); NA, not applicable; SNRA, seronegative rheumatoid arthritis; SPRA, seropositive rheumatoid arthritis.